ANVS - Annovis Bio, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Annovis Bio, Inc.
IPO Date: January 29, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $48.65M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.72 | 5.07%
Avg Daily Range (30 D): $0.05 | 3.33%
Avg Daily Range (90 D): $0.07 | 3.74%
Institutional Daily Volume
Avg Daily Volume: .47M
Avg Daily Volume (30 D): .99M
Avg Daily Volume (90 D): .97M
Trade Size
Avg Trade Size (Sh.): 147
Avg Trade Size (Sh.) (30 D): 330
Avg Trade Size (Sh.) (90 D): 284
Institutional Trades
Total Institutional Trades: 48
Avg Institutional Trade: $1.41M
Avg Institutional Trade (30 D): $.61M
Avg Institutional Trade (90 D): $.65M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.63M
Avg Closing Trade (30 D): $.61M
Avg Closing Trade (90 D): $.65M
Avg Closing Volume: 109.58K
 
News
Aug 25, 2026 @ 12:00 PM
Annovis to Host Corporate Update Webinar on Septem...
Source: Not Specified
Nov 24, 2025 @ 1:00 PM
Annovis Announces Two Presentations at the CTAD 20...
Source: Maria Maccecchini, Ph.D.
Jul 8, 2025 @ 5:00 PM
Alzheimer’s Therapeutics Market on Upward T...
Source: Delveinsight
Mar 25, 2025 @ 12:00 PM
Annovis to Attend AD/PD™ 2025 with Extens...
Source: N/A
Mar 3, 2025 @ 6:00 PM
LEQEMBI Market Sales Reflect Growing Confidence in...
Source: Delveinsight
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.75 $-.4 $-.63
Diluted EPS $-1.75 $-.4 $-.63
Revenue $M $M $M
Gross Profit
Net Income / Loss $-49.52M $-14.82M $-17.61M
Operating Income / Loss $-49.53M $-14.38M $-18.01M
Cost of Revenue
Net Cash Flow $M $M $M
PE Ratio